BRONCHODEX D CAP CAPSULE (SUSTAINED-RELEASE) Канада - англійська - Health Canada

bronchodex d cap capsule (sustained-release)

prodemdis enr. - phenylpropanolamine hydrochloride; chlorpheniramine maleate; pheniramine maleate - capsule (sustained-release) - 50mg; 1mg; 12.5mg - phenylpropanolamine hydrochloride 50mg; chlorpheniramine maleate 1mg; pheniramine maleate 12.5mg - propylamine derivatives

TRIAMINIC TIME RELEASE TAB TABLET (EXTENDED-RELEASE) Канада - англійська - Health Canada

triaminic time release tab tablet (extended-release)

novartis consumer health canada inc. - phenylpropanolamine hydrochloride; pheniramine maleate; pyrilamine maleate - tablet (extended-release) - 50mg; 25mg; 25mg - phenylpropanolamine hydrochloride 50mg; pheniramine maleate 25mg; pyrilamine maleate 25mg - first generation antihistamines

DIMETAPP LIQUI-GELS CAP CAPSULE Канада - англійська - Health Canada

dimetapp liqui-gels cap capsule

whitehall-robins inc. - phenylpropanolamine hydrochloride; brompheniramine maleate - capsule - 25mg; 4mg - phenylpropanolamine hydrochloride 25mg; brompheniramine maleate 4mg - propylamine derivatives

CORSYM SUSPENSION Канада - англійська - Health Canada

corsym suspension

ciba self medication - phenylpropanolamine hydrochloride; chlorpheniramine maleate - suspension - 37.5mg; 4mg - phenylpropanolamine hydrochloride 37.5mg; chlorpheniramine maleate 4mg - propylamine derivatives

DIMETAPP CLEAR LIQUID Канада - англійська - Health Canada

dimetapp clear liquid

whitehall-robins inc. - phenylpropanolamine hydrochloride; brompheniramine maleate - liquid - 12.5mg; 2mg - phenylpropanolamine hydrochloride 12.5mg; brompheniramine maleate 2mg - propylamine derivatives

TRIAMINIC COLD AND ALLERGY SYRUP Канада - англійська - Health Canada

triaminic cold and allergy syrup

novartis consumer health canada inc. - phenylpropanolamine hydrochloride; chlorpheniramine maleate - syrup - 12.5mg; 2mg - phenylpropanolamine hydrochloride 12.5mg; chlorpheniramine maleate 2mg - propylamine derivatives

CONTAC COLD CAPSULES CAPSULE (SUSTAINED-RELEASE) Канада - англійська - Health Canada

contac cold capsules capsule (sustained-release)

smithkline beecham consumer healthcare, division of smithkline beecham inc. - phenylpropanolamine hydrochloride; chlorpheniramine maleate - capsule (sustained-release) - 75mg; 8mg - phenylpropanolamine hydrochloride 75mg; chlorpheniramine maleate 8mg - propylamine derivatives

CONTAC COLD EXTRA STRENGTH CAPSULES CAPSULE (SUSTAINED-RELEASE) Канада - англійська - Health Canada

contac cold extra strength capsules capsule (sustained-release)

smithkline beecham consumer healthcare, division of smithkline beecham inc. - phenylpropanolamine hydrochloride; chlorpheniramine maleate - capsule (sustained-release) - 75mg; 12mg - phenylpropanolamine hydrochloride 75mg; chlorpheniramine maleate 12mg - propylamine derivatives

TERAZOSIN HYDROCHLORIDE capsule США - англійська - NLM (National Library of Medicine)

terazosin hydrochloride capsule

preferred pharmaceuticals, inc - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 1 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

TERAZOSIN HYDROCHLORIDE capsule США - англійська - NLM (National Library of Medicine)

terazosin hydrochloride capsule

stat rx usa llc - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 5 mg - terazosin hydrochloride capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin hydrochloride. the long term effects of terazosin on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin hydrochloride capsule is also indicated for the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.